LBA6Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC. (17th December 2018)

Record Type:: Journal Article
Title:: LBA6Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC. (17th December 2018)
Main Title:: LBA6Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC
Authors:: Rizvi, N A
Chul Cho, B
Reinmuth, N
Lee, K H
Ahn, M-J
Luft, A
van den Heuvel, M
Cobo, M
Smolin, A
Vicente, D
Moiseyenko, V
Antonia, S J
Le Moulec, S
Robinet, G
Natale, R
Nakagawa, K
Zhao, L
Stockman, P K
Chand, V
Peters, S
Abstract:
Is Part Of:: Annals of oncology. Volume 29(2018)Supplement 10
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 10
Issue Display:: Volume 29, Issue 10 (2018)
Year:: 2018
Volume:: 29
Issue:: 10
Issue Sort Value:: 2018-0029-0010-0000
Page Start:
Page End:
Publication Date:: 2018-12-17
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy511.005 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12263.xml